thymoquinone has been researched along with Neuroendocrine Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asa, SL; Azmi, AS; Bajor, D; Cjakrabarti, S; Kaseb, AO; Mahipal, A; Mohamed, A; Selfridge, JE; Tirumani, SH | 1 |
1 other study(ies) available for thymoquinone and Neuroendocrine Tumors
| Article | Year |
|---|---|
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination.
Topics: Carcinoma, Neuroendocrine; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Infant, Newborn; Ipilimumab; Lung Neoplasms; Neuroendocrine Tumors; Nivolumab; Quality of Life | 2022 |